[Cardiac troponin I determination in patients with chronic renal failure]

L M Flores1, J L Hernández Dominguez, A Otero

  • 1Servicio de Análisis Clínicos, Complejo Hospitalario de Ourense, Universitario de Santiago de Compostela.

Insights

Cardiac troponin I (cTnI) is a preferred biomarker for myocardial damage in chronic renal failure (CRF) patients. Adjusting the cTnI cut-off value may improve acute myocardial injury diagnosis in this population.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarker analysis

Context:

  • Chronic renal failure (CRF) presents diagnostic challenges for myocardial injury.
  • Standard biomarkers may be affected by renal dysfunction.
  • Accurate diagnosis of acute myocardial injury (AMI) is critical in CRF patients.

Purpose:

  • To evaluate cardiac troponin I (cTnI) determination in patients with chronic renal failure (CRF).
  • To compare cTnI with creatine kinase-MB isoenzyme (CK-MB) for diagnosing myocardial injury.
  • To assess the diagnostic performance of cTnI in CRF patients.

Summary:

  • A retrospective study analyzed cTnI levels in CRF patients with suspected myocardial injury.
  • cTnI diagnosed AMI in 10% of patients (cut-off > 0.05 ng/mL).
  • Sensitivity was 70% and specificity 92% for cTnI with a cut-off > 0.5 ng/mL, with 31% false positives.

Impact:

  • cTnI is identified as the preferred biomarker for myocardial damage in CRF.
  • Findings suggest that alternative cut-off values for cTnI could enhance AMI detection.
  • This research aids in refining diagnostic strategies for cardiac events in renal disease.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...